Korean J Anesthesiol Search

CLOSE


Korean J Anesthesiol > Volume 74(4); 2021 > Article
Hamilton: Local anesthetic systemic toxicity following erector spinae plane block: sometimes less is more
In their recent communication Yawata et al. [1] report a case of local anesthetic systemic toxicity (LAST) following ultrasound guided lumbar erector spinae plane block (ESPB) in a patient undergoing endoscopic surgery for lumbar spinal stenosis. I commend the authors for sharing their experience, although contrary to their assertion there has in fact been a previous report of this complication in the literature [2]. However, the previous report by Karaca and Pinar [2] had critical omissions that made it of limited value, most notably the body weight of the patient, and the concentration of local anesthetic (LA) drugs used.
Yawata et al. [1] report the use of a total volume of 30 ml of 0.5% (150 mg) levobupivacaine in a 58 kg man (body mass index 21.8 kg/m2). They describe the use of techniques designed to minimize the risk of inadvertent intravascular injection, observing linear spread of injectate in the plane deep to the erector spinae muscle, and the absence of blood on aspiration. In common with the previous report the principal manifestations of LAST following ESPB were neurological.
Interfascial (or fascial) plane blocks are regarded as ‘volume’ blocks. The underlying principle is that a volume of LA is injected into a fascial plane remote from the intended site(s) of action. The LA has to traverse the fascial plane to reach the intended target nerve(s). This is in direct contrast to nerve blocks or plexus blocks, where the neural target is visualized using ultrasound and LA is deliberately deposited in close proximity to neural structures, often permitting the use of lower volumes of LA. In contrast to ‘traditional’ nerve blocks fascial plane blocks are rarely used as a sole anesthetic technique.
The use of ESPB for surgery of the lumbar spine remains controversial at this time [3], although there is evidence that ESPB reliably blocks the dorsal ramus of the spinal nerves [4]. Thus, of all the reported uses of ESPB to date, its use in back surgery is one of the most promising areas for further investigation [5].
It could be argued that the risk of LAST could be reduced by using a lower concentration of LA, while still utilizing the required volume. There is a paucity of data comparing the duration of action of different concentrations of LA in fascial plane blocks. Similarly, the maximum safe dose of LA for fascial plane blocks has not yet been formally elucidated. Therefore, in the interest of patient safety it would seem wise when using large volumes of LA to use a lower concentration of LA (such as 0.25% rather than 0.5% levobupivacaine) for ESPB.
While there remain many unanswered questions about ESPB, there is certainly no evidence of reduced efficacy of ESPB with lower concentrations of levobupivacaine.

Conflicts of Interest

No potential conflict of interest relevant to this article was reported.

References

1. Yawata S, Imamachi N, Sakura S, Yamamoto H, Saito Y. Local anesthetic systemic toxicity of levobupivacaine in erector spinae plane block. Korean J Anesthesiol 2021; 74: 271-2.
crossref pmid
2. Karaca O, Pinar HU. Is high dose lumbar erector spinae plane block safe? J Clin Anesth 2020; 62: 109721.
crossref pmid
3. Qiu Y, Zhang TJ, Hua Z. Erector Spinae Plane Block for Lumbar Spinal Surgery: A Systematic Review. J Pain Res 2020; 13: 1611-9.
crossref pmid pmc
4. Zhang J, He Y, Wang S, Chen Z, Zhang Y, Gao Y, et al. The erector spinae plane block causes only cutaneous sensory loss on ipsilateral posterior thorax: a prospective observational volunteer study. BMC Anesthesiol 2020; 20: 88.
crossref pmid pmc
5. Lonnqvist PA, Karmakar MK, Richardson J, Moriggl B. Daring discourse: should the ESP block be renamed RIP II block? Reg Anesth Pain Med 2021; 46: 57-60.
crossref pmid


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
AUTHOR INFORMATION
Editorial Office
101-3503, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
(서울특별시 마포구 마포대로 109 롯데캐슬 프레지던트 101동 3503호)
Tel: +82-2-792-5128    Fax: +82-2-792-4089    E-mail: journal@anesthesia.or.kr                
Business Name: Korean Society of Anesthesiologists (대한마취통증의학회)
Business Registration: 106-82-07194
Representative: Jun Heum Yon (연준흠)

Copyright © 2024 by Korean Society of Anesthesiologists.

Developed in M2PI

Close layer
prev next